Categories: Government agency news release

1 2/22/2018

Potential harms and source of evidence missing in FDA summary of new blood test for concussion

2/15/2018

NIH recap on ‘brain disease test’: strong on study results, but lacks clarity on patient benefits

5/5/2017

Key detail missing in FDA approval of new acute myeloid leukemia drug: How much longer do people live?

4/4/2017

FDA could do a better job sharing numbers on costly new eczema drug

3/14/2017

FDA omits numbers on drug to reduce night-time visits to the bathroom; placebo was nearly as good

2/20/2017

FDA announces approval of new psoriasis drug with strong caveats on harms, but no data to support benefit claim

2/7/2017

NIH gives crisp summary of early stem cell transplants for multiple sclerosis, but missed some limitations

2 1/31/2017

How big is symptom improvement with new constipation drug? Readers might have to strain to find out

1/4/2017

Fenofibrate as add-on to statins for type 2 diabetes: NIH release promotes possible benefit found only in small subgroup of patients

11/28/2016

FDA release on Intrarosa approval omits important conflict of interest